ROCHESTER, N.Y.--(BUSINESS WIRE)--April 12, 2006--Biophan Technologies, Inc. (OTCBB: BIPH; FWB: BTN), a developer of next-generation medical technology, announced today that Dr. Stephen H. Curry will assume the role of President of Biophan’s Nanolution drug delivery division. Dr. Curry, formerly with AstraZeneca (NYSE: AZN - News), has extensive experience in the pharmaceutical and biotechnology industry as well as academia, working in both arenas in parallel over the last 15 years.
